1. The global regenerative medicine market is expected to reach $48.9 billion by 2021, growing at a CAGR of 23.24 percent.
2. Key players in the market include Acelity, Celgene, NuVasive, StemCells and Vertex Pharmaceuticals.
3. The surge in market growth is attributed to technological advancements and demand for biologically derived materials, along with government support for tissue engineering therapies.
More articles on orthopedics:
5 trends for orthopedic surgeons to watch in 2017
Northwestern researchers print bone implants with 3-D printers: 4 notes
Osteoporosis screening, monitoring recommendations released by AAOS: 3 notes
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
